Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
02181 MABPHARM-B
RT Nominal unchange0.780 0.000 (0.000%)
Latest  |  Final  |  Interim
Non-current Assets
2025/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2024/06
RMB(K¥)
2023/06
RMB(K¥)
2022/06
RMB(K¥)
2021/06
RMB(K¥)
Investment Properties0--0000
Property, plant, equip. & others532,623-3.467%590,824621,689596,266406,386
Land & other Lease Assets59,844-4.237%66,68463,53372,80969,640
Intangible Assets61,69785.026%0000
Interests in Asso. & JCEs0--0000
Other Non-current Assets3,38418.570%5,8167,53544,700104,637

657,5481.092%663,324692,757713,775580,663
Current Assets
2025/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2024/06
RMB(K¥)
2023/06
RMB(K¥)
2022/06
RMB(K¥)
2021/06
RMB(K¥)
Inventories145,78231.324%101,703103,23780,35837,664
Trade Receivables145,33553.751%64,15129,0103,85011,468
Cash & Bank Balances94,1625.393%74,06623,14280,286307,178
Other Current Assets25,019-64.710%43,15054,80359,73541,652
Assets Held for Sale0--0000

410,29812.173%283,070210,192224,229397,962
Current Liabilities
2025/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2024/06
RMB(K¥)
2023/06
RMB(K¥)
2022/06
RMB(K¥)
2021/06
RMB(K¥)
Trade Payables29,235149.680%12,24616,35728,8746,472
S-T Debt & Leases110,14213.244%48,07263,79013,3907,597
Other Current Liabilities243,63119.924%204,994173,717180,757177,761
Liab asso w/ Assets Held for Sale0--0000

383,00822.710%265,312253,864223,021191,830
Net Current Assets27,290-49.132%17,758(43,672)1,208206,132
Total Assets Less Current Liabilities684,838-2.735%681,082649,085714,983786,795
Non-current Liabilities
2025/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2024/06
RMB(K¥)
2023/06
RMB(K¥)
2022/06
RMB(K¥)
2021/06
RMB(K¥)
L-T Debt & Leases194,868-0.492%195,56083,682113,29529,901
Other Non-current Liabilities391,107-6.730%370,331258,780110,56014,000

585,975-4.744%565,891342,462223,85543,901
Capital and Reserves
2025/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2024/06
RMB(K¥)
2023/06
RMB(K¥)
2022/06
RMB(K¥)
2021/06
RMB(K¥)
  Share Capital2,8040.000%2,8042,8042,8042,804
  Reserves96,05911.528%112,387303,819488,324740,090
  Others0--0000
Shareholders' Funds98,86311.164%115,191306,623491,128742,894
Non-controlling Interests0--0000
Others0--0000

98,86311.164%115,191306,623491,128742,894
Commitments and Contingent Liabilities
2025/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2024/06
RMB(K¥)
2023/06
RMB(K¥)
2022/06
RMB(K¥)
2021/06
RMB(K¥)
Commitments------------
Contingent Liabilities------------
Remarks:  Real time quote last updated: 11/09/2025 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (K¥)RMB 2,898
%Change--
EPS / (LPS)RMB 0.001
NBV Per Share (¥)RMB 0.024
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2025 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.